Patent ID: 7820673

Claim:
A compound represented by Formula (1): wherein Cy is a phenyl which may be substituted with a halogen atom or a C 2-4 alkylene; R 1 is a hydrogen atom; V is —C(O); W is —NH—; X is a methylene which may be substituted with (1) a C 1-6 alkyl, (2) a C 2-6 alkenyl, (3) a C 2-6 alkynyl, (4) a phenyl, (5) a C 3-7 cycloalkyl, (6) a C 3-6 cycloalkenyl, (7) a C 7-16 aralkyl or (8) a 5- to 6-membered aromatic monocyclic heterocyclic group, where each of the C 1-6 alkyl of (1), the C 2-6 alkenyl of (2), the C 2-6 alkynyl of (3), the phenyl of (4), the C 3-7 cycloalkyl of (5), the C 3-6 cycloalkenyl of (6), the C 7-16 aralkyl of (7) and the 5- to 6-membered aromatic monocyclic heterocyclic group of (8) may be substituted with (i) a hydroxyl group, (ii) a thiol group which may be substituted with C 1-6 alkyl, (iii) a carboxyl, (iv) a C 1-6 alkoxycarbonyl, (v) an acyl, (vi) an amino which may be substituted with lower alkyl, carboxyl, C 1-6 alkoxycarbonyl or acyl, (vii) a halogen atom, (viii) a carbamoyloxy, (ix) a nitro group, (x) a cyano group, (xi) a lower alkyl which may be substituted with 1 to 5 halogen atoms, (xii) a phenyl which may be substituted with 1 to 5 halogen atoms, (xiii) a lower alkoxy which may be substituted with a phenyl or 1 to 5 halogen atoms, (xiv) a 5- to 6-membered aromatic monocyclic heterocyclic group or (xv) a thioxo; Y is —C(O); Z is a bond or a C 1-6 alkylene; ring A is a piperadine ring which may be substituted, or a piperazine ring which may be substituted; ring B is a piperazine ring which may be substituted, an imidazoline ring which may be substituted, an imidazole ring which may be substituted, a thiazoline ring which may be substituted, or a fused nitrogen-containing heterocyclic ring which may be substituted; and , is each independently a single bond or a double bond, or a salt thereof.